Table 1.

Epidemiological studies on the prevalence of Peyronie's disease

Authors and year	Country	Evaluation	Age range	Prevalence (%)
Lindsay et al, 19918	USA	General population	Not specified	0.38
Schwarzer et al, 20019	Germany	General population	30–80 years	3.2
La Pera et al, 200110	Italy	Smokers	50–60 years	7.2
Rhoden et al, 200111	Brazil	Prostate cancer screening	52–77 years	3.67
Mulhall et al, 200412	USA	Prostate cancer screening	40–80 years	8.9
Kadioglu A. et al, 200413	Turkey	Erectile dysfunction	Not specified	16
El-Sakka 200614	Egypt	Erectile dysfunction	Not specified	7.9
Arafa et al, 200615	Egypt	Diabetic patients and ED	Not specified	20.3
Tefekli et al, 200616	Turkey	Diabetic patients	Not specified	22.5
Akbal et al, 200817	Turkey	Retroperitoneal fibrosis	Not specified	20
Dibenedetti et al, 201118	USA	General population	>18 years	0.5 to 13
Shiraishi 201219	Japan	General population and men undergoing hemodialysis	Not specified	0.6 to 9.2
Romero et al, 201320	Brazil	Prostate cancer screening	>40 years	0.9
Stuntz et al, 201621	USA	General population	>18 years	10.8

ED = erectile dysfunction.